A 2024 BMJ Public Health study on excess mortality during the COVID-19 pandemic faced strong criticism for methodological flaws and for potentially spreading misinformation about its causes, without establishing a link to Covid vaccination.

BMJ Public Health retracted the paper, which had claimed that excess mortality remained abnormally high after the pandemic peak in several regions and fueled vaccine-skeptic narratives online.

The journal acknowledged action was taken to withdraw the paper, marking a corrective step in scientific publishing.

An institutional report indicated no evidence of malicious intent, fabrication, falsification, or plagiarism by the investigated authors, though the full report from the Princess Máxima Center has not been released publicly.

Following investigations and an initial expression of concern in 2024, the paper has now been fully retracted with support from the institution and two of the four authors.

The retraction represents the most severe form of disavowal for a scientific paper, formally removing its findings from the scientific record, and a cautionary publisher notice preceded the final withdrawal.

Corresponding author initially did not cooperate with the inquiry but later expressed willingness to make changes; editors deemed those changes insufficient due to imbalanced discussion, lack of rigor, and misinformation.

The investigation found the paper misrepresented literature by citing sources supporting its argument while neglecting opposing viewpoints.

The retraction followed broader scrutiny, including media coverage and critiques about the re-analysis period (2020–2022) and changing excess mortality trends.

The case sits within the broader context of how excess mortality estimates during the pandemic were communicated by researchers, media, and policymakers.

Coverage in outlets like NZ Doctor suggested the study was widely misreported, potentially overstating conclusions in public discourse.

The episode underscores ongoing scrutiny of Covid-related research and emphasizes the need for robust, transparent methodologies to avoid fueling vaccine misinformation.